Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$5.16 - $7.98 $161,549 - $249,837
-31,308 Closed
0 $0
Q1 2021

Apr 27, 2021

BUY
$7.25 - $13.82 $11,600 - $22,112
1,600 Added 5.39%
31,308 $244,000
Q4 2020

Jan 25, 2021

BUY
$6.87 - $10.48 $123,027 - $187,675
17,908 Added 151.76%
29,708 $275,000
Q3 2020

Nov 06, 2020

BUY
$5.06 - $7.23 $59,707 - $85,314
11,800 New
11,800 $81,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.